Carla Hassler

Title: The Innovative Contributions of Carla Hassler

Introduction

Carla Hassler is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of neuropeptide research, holding a total of 3 patents. Her work focuses on the development of neuropeptide S receptor (NPSR) agonists, which have potential therapeutic applications for various disorders.

Latest Patents

Hassler's latest patents include innovative formulations of neuropeptide S receptor agonists. These agonists consist of trimeric, tetrameric, pentameric, or hexameric peptidomimetic analogs that exhibit strong affinity for and activity at the neuropeptide S receptor. The therapeutic potential of these molecules is vast, as they may be useful in treating conditions such as substance abuse, narcolepsy, insomnia, obesity, cognitive decline, dementia, Alzheimer's disease, panic disorder, generalized anxiety, PTSD, phobias, and schizophrenia. Additionally, they can serve as supportive medication during cessation programs in cognitive behavioral therapy for issues like drug addiction, eating disorders, and gambling.

Career Highlights

Carla Hassler is affiliated with the Research Triangle Institute, where she continues to advance her research in neuropeptide S receptor agonists. Her work is characterized by a commitment to addressing complex health issues through innovative scientific solutions.

Collaborations

Hassler collaborates with notable colleagues, including Scott P Runyon and Danni Harris. These partnerships enhance her research efforts and contribute to the development of effective therapeutic strategies.

Conclusion

Carla Hassler's contributions to the field of neuropeptide research exemplify the impact of innovative thinking in addressing significant health challenges. Her work on neuropeptide S receptor agonists holds promise for improving treatment options for various disorders.